AMAG Pharmaceuticals to Present at Upcoming Investor Conference
September 01 2016 - 9:15AM
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that
company management will participate in an analyst-led fireside chat
at the Morgan Stanley Global Healthcare Conference on Monday,
September 12, 2016 at 10:30 a.m. EDT.
A live audio webcast of the discussion will be accessible
through the Investors section of the company’s website
at www.amagpharma.com and will be archived for 30
days.
About AMAGAMAG is a
biopharmaceutical company focused on developing and delivering
important therapeutics, conducting clinical research in areas of
unmet need and creating education and support programs for the
patients and families we serve. Our products support the health of
patients in the areas of maternal health, anemia management and
cancer supportive care. Through CBR®, we also help families to
preserve newborn stem cells, which are used today in transplant
medicine for certain cancers and blood, immune and metabolic
disorders, and have the potential to play a valuable role in the
ongoing development of regenerative medicine. For additional
company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG
Pharmaceuticals, Inc. and CBR® is a registered trademark
of CBR Systems, Inc.
AMAG Pharmaceuticals Contact:
Linda Lennox
Vice President, Investor Relations
617-498-2846
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Mar 2024 to Apr 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Apr 2023 to Apr 2024